Financhill
Sell
33

INFU Quote, Financials, Valuation and Earnings

Last price:
$6.03
Seasonality move :
-4.37%
Day range:
$5.91 - $6.17
52-week range:
$4.61 - $9.97
Dividend yield:
0%
P/E ratio:
42.50x
P/S ratio:
0.93x
P/B ratio:
2.26x
Volume:
76K
Avg. volume:
155K
1-year change:
-13.64%
Market cap:
$124.8M
Revenue:
$134.9M
EPS (TTM):
$0.14

Analysts' Opinion

  • Consensus Rating
    InfuSystems Holdings has received a consensus rating of Buy. The company's average rating is a Buy based on 4 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $13.63, InfuSystems Holdings has an estimated upside of 128.99% from its current price of $5.95.
  • Price Target Downside
    According to analysts, the lowest downside price target is $12.00 representing 100% downside risk from its current price of $5.95.

Fair Value

  • According to the consensus of 4 analysts, InfuSystems Holdings has 128.99% upside to fair value with a price target of $13.63 per share.

INFU vs. S&P 500

  • Over the past 5 trading days, InfuSystems Holdings has overperformed the S&P 500 by 4.14% suggesting its relative strength compared to the major market average is strong at this time.

Share Buyback

  • InfuSystems Holdings does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • InfuSystems Holdings has grown year-over-year revenues for 15 quarters straight. In the most recent quarter InfuSystems Holdings reported revenues of $34.7M.

Earnings Growth

  • InfuSystems Holdings has grown year-over-year earnings for 3 quarters straight. In the most recent quarter InfuSystems Holdings reported earnings per share of -$0.01.
Enterprise value:
152M
EV / Invested capital:
1.81x
Price / LTM sales:
0.93x
EV / EBIT:
18.39x
EV / Revenue:
1.10x
PEG ratio (5yr expected):
0.01x
EV / Free cash flow:
66.41x
Price / Operating cash flow:
56.01x
Enterprise value / EBITDA:
7.17x
Gross Profit (TTM):
$73.1M
Return On Assets:
3.03%
Net Income Margin (TTM):
2.32%
Return On Equity:
5.82%
Return On Invested Capital:
3.81%
Operating Margin:
1.78%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-03-31 2024-03-31 2025-03-31 2024-03-31 2025-03-31
Income Statement
Revenue $113.5M $127.4M $137.6M $32M $34.7M
Gross Profit $60.1M $64.6M $73.1M $16.5M $19.2M
Operating Income $2.1M $3.4M $8.4M -$845K $618K
EBITDA $15.1M $15.5M $21.2M $2.1M $3.9M
Diluted EPS -- $0.00 $0.14 -$0.05 -$0.01
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Balance Sheet
Current Assets $23.5M $23.3M $27.9M $32.5M $35.3M
Total Assets $90.6M $98.2M $102.3M $104.9M $104.3M
Current Liabilities $12.2M $13.9M $13.9M $17.3M $16M
Total Liabilities $47.6M $52.2M $54M $52.6M $49.1M
Total Equity $42.9M $46.1M $48.3M $52.3M $55.1M
Total Debt $32.4M $34.9M $36.4M $29.9M $28.7M
Trailing 12 Months Fiscal Quarters
Period Ending 2023-03-31 2024-03-31 2025-03-31 2024-03-31 2025-03-31
Cash Flow Statement
Cash Flow Operations $13.3M $11.8M $21.9M $377K $1.8M
Cash From Investing -$12.4M -$4.1M -$15.5M -$418K -$2.7M
Cash From Financing -$1.1M -$7.1M -$5.7M $632K $1.9M
Free Cash Flow -$3M $3.2M $2.3M -$1.3M -$1.6M
INFU
Sector
Market Cap
$124.8M
$33.8M
Price % of 52-Week High
59.68%
46.95%
Dividend Yield
0%
0%
Shareholder Yield
4.28%
-0.6%
1-Year Price Total Return
-13.64%
-37.45%
Beta (5-Year)
1.809
0.632
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

Technicals

8-day SMA
Buy
Level $5.90
200-day SMA
Sell
Level $6.88
Bollinger Bands (100)
Sell
Level 5.04 - 7.62
Chaikin Money Flow
Sell
Level -2.1M
20-day SMA
Buy
Level $5.81
Relative Strength Index (RSI14)
Buy
Level 56.38
ADX Line
Buy
Level 24.48
Williams %R
Neutral
Level -21.6216
50-day SMA
Buy
Level $5.33
MACD (12, 26)
Buy
Level 0.16
25-day Aroon Oscillator
Buy
Level 32
On Balance Volume
Neutral
Level 188.4K

Financial Scores

Buy
Altman Z-Score (Annual)
Level (3.2512)
Buy
CA Score (Annual)
Level (0.4925)
Buy
Beneish M-Score (Annual)
Level (-3.2839)
Buy
Momentum Score
Level (3)
Buy
Ohlson Score
Level (0.016)
Buy
Piotroski F Score (Annual)
Level (8)
Buy
Quality Ratio Score
Level (8)
Buy
Fundamental Score
Level (7)

Revenue Forecast

Earnings per Share Forecast

Company Profile

InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. INFU services are provided under a two-reportable segment. The first is Patient Services, providing the last-mile solution for clinic-to-home healthcare where the continuing treatment involves complex durable medical equipment and services. The Patient segment is comprised of Oncology, Pain Management and Wound Therapy businesses. The second, Device Solutions, supports the Patient Services platform and leverages service orientation to win incremental business from its direct payer clients. The Device segment is comprised of direct payer rentals, pump and consumable sales, and biomedical services and repair. Majority from Patient.

Stock Forecast FAQ

In the current month, INFU has received 4 Buy ratings 0 Hold ratings, and 0 Sell ratings. The INFU average analyst price target in the past 3 months is $13.63.

  • Where Will InfuSystems Holdings Stock Be In 1 Year?

    According to analysts, the consensus estimate is that InfuSystems Holdings share price will rise to $13.63 per share over the next 12 months.

  • What Do Analysts Say About InfuSystems Holdings?

    Analysts are divided on their view about InfuSystems Holdings share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that InfuSystems Holdings is a Sell and believe this share price will drop from its current level to $12.00.

  • What Is InfuSystems Holdings's Price Target?

    The price target for InfuSystems Holdings over the next 1-year time period is forecast to be $13.63 according to 4 Wall Street analysts, 4 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is INFU A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for InfuSystems Holdings is a Buy. 4 of 4 analysts rate the stock a Buy at this time.

  • How Can I Buy Shares Of INFU?

    You can purchase shares of InfuSystems Holdings via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase InfuSystems Holdings shares.

  • What Is The InfuSystems Holdings Share Price Today?

    InfuSystems Holdings was last trading at $6.03 per share. This represents the most recent stock quote for InfuSystems Holdings. Yesterday, InfuSystems Holdings closed at $5.95 per share.

  • How To Buy InfuSystems Holdings Stock Online?

    In order to purchase InfuSystems Holdings stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Where Will VICI Properties Be in 5 Years?
Where Will VICI Properties Be in 5 Years?

VICI Properties (NYSE:VICI) is a real estate investment trust focused…

Where Will Exxon Stock Be in 5 Years?
Where Will Exxon Stock Be in 5 Years?

For sure Exxon Mobil (NYSE: XOM) is no hyped-up AI…

How High Will Dollar General Stock Go?
How High Will Dollar General Stock Go?

Shares of Dollar General (NYSE:DG) have risen significantly in recent…

Stock Ideas

Buy
68
Is MSFT Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 40x

Buy
64
Is NVDA Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 49x

Sell
39
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Alerts

Buy
59
SBET alert for Jun 10

SharpLink Gaming [SBET] is up 14.34% over the past day.

Buy
85
ASTS alert for Jun 10

AST SpaceMobile [ASTS] is up 2.58% over the past day.

Buy
69
CCJ alert for Jun 10

Cameco [CCJ] is down 4.56% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock